The future of monoclonal antibody engineering

Ann Hematol. 2001:80 Suppl 3:B127-9. doi: 10.1007/pl00022775.

Authors

C Renner¹, F Hartmann, M Pfreundschuh

Affiliation

¹ Med. Dept. I, Saarland University Medical School, Homburg/Saar, Germany. [email protected]

PMID: 11757694
DOI: 10.1007/pl00022775

No abstract available

Publication types

Review

MeSH terms

Antibodies, Monoclonal* / chemistry
Antibodies, Monoclonal* / genetics
Antibodies, Monoclonal* / immunology
Antibodies, Monoclonal* / therapeutic use
Drug Design
Forecasting
Genes, Immunoglobulin
Humans
Immunoglobulin Variable Region / genetics
Immunoglobulin Variable Region / immunology
Lymphoma / diagnosis
Lymphoma / immunology
Lymphoma / radiotherapy
Lymphoma / therapy
Protein Engineering* / trends
Radioimmunotherapy
Recombinant Fusion Proteins / chemistry
Recombinant Fusion Proteins / genetics
Recombinant Fusion Proteins / immunology
Recombinant Fusion Proteins / therapeutic use
Structure-Activity Relationship

Substances

Antibodies, Monoclonal
Immunoglobulin Variable Region
Recombinant Fusion Proteins